Lv5187
1100 积分 2024-09-05 加入
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
3天前
已完结
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
14天前
已完结
Pathogenic cellular and molecular mediators in lupus nephritis
16天前
已完结
Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review
16天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
16天前
已完结
Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study
16天前
已完结
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
16天前
已完结
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
16天前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
17天前
已完结
Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial
19天前
已完结
皖公网安备34019202002308
